Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatarkiewicz

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|August 1, 1997
[Experiments with pancreas islet xenotransplantation]E Sitarek, K Tatarkiewicz, M Sabat, et al.
Development, Growth & Differentiation|March 13, 2003
Development and retroviral transduction of porcine neonatal pancreatic islet cells in monolayer cultureKrystyna Tatarkiewicz, Maria D López-Avalos, Kun-Ho Yoon, et al.
Cell Transplantation|March 4, 2000
Differentiation and expansion of beta cell mass in porcine neonatal pancreatic cell clusters transplanted into nude miceK H Yoon, R R Quickel, K Tatarkiewicz, et al.
Transplantation Proceedings|December 1, 1994
Preliminary study of a new method for monitoring viability of transplanted islets of LangerhansP Fiedor, K Tatarkiewicz, E Sitarek, et al.
Diabetes, Obesity & Metabolism|March 27, 2014
The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeysD Roy, K D Chadwick, K Tatarkiewicz, et al.
Diabetes, Obesity & Metabolism|September 11, 2014
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodentsJ L Trevaskis, C Sun, J Athanacio, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 7, 2010
Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodentsKrystyna Tatarkiewicz, Pamela A Smith, Emmanuel J Sablan, et al.
Plos One|February 8, 2014
Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of actionOdile E Levy, Carolyn M Jodka, Shijun Steven Ren, et al.
Diabetes, Obesity & Metabolism|July 18, 2013
A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodentsK Tatarkiewicz, D M Hargrove, C M Jodka, et al.
Plos One|October 30, 2013
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybridsJames L Trevaskis, Christine M Mack, Chengzao Sun, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Polskie Archiwum Medycyny Wewnetrznej|August 1, 1997
[Experiments with pancreas islet xenotransplantation]E Sitarek, K Tatarkiewicz, M Sabat, et al.
Development, Growth & Differentiation|March 13, 2003
Development and retroviral transduction of porcine neonatal pancreatic islet cells in monolayer cultureKrystyna Tatarkiewicz, Maria D López-Avalos, Kun-Ho Yoon, et al.
Cell Transplantation|March 4, 2000
Differentiation and expansion of beta cell mass in porcine neonatal pancreatic cell clusters transplanted into nude miceK H Yoon, R R Quickel, K Tatarkiewicz, et al.
Transplantation Proceedings|December 1, 1994
Preliminary study of a new method for monitoring viability of transplanted islets of LangerhansP Fiedor, K Tatarkiewicz, E Sitarek, et al.
Diabetes, Obesity & Metabolism|March 27, 2014
The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeysD Roy, K D Chadwick, K Tatarkiewicz, et al.
Diabetes, Obesity & Metabolism|September 11, 2014
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodentsJ L Trevaskis, C Sun, J Athanacio, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 7, 2010
Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodentsKrystyna Tatarkiewicz, Pamela A Smith, Emmanuel J Sablan, et al.
Plos One|February 8, 2014
Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of actionOdile E Levy, Carolyn M Jodka, Shijun Steven Ren, et al.
Diabetes, Obesity & Metabolism|July 18, 2013
A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodentsK Tatarkiewicz, D M Hargrove, C M Jodka, et al.
Plos One|October 30, 2013
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybridsJames L Trevaskis, Christine M Mack, Chengzao Sun, et al.
Pageof 6